San Diego Chapter eNEWS
Dr. Itamar Kahn Engages Guests With Discussion of Technion Advances in Parkinson's Research

Earlier this month, Dr. Itamar Kahn, Assistant Professor at the Technion Rappaport Faculty of Medicine, provided guests at the home of Del Mar residents Steven & Diane Demeter with some enlightening information about Technion advances in Parkinson's Disease research. 

Dr. Itamar Kahn (center) with Diane & Steven Demeter
Dr. Kahn focuses his research on brain function and behavior in health and disease, and in particular, failures of communication between brain systems. His work has applications for better understanding and treating brain disorders including neurodegenerative diseases like Alzheimer's disease & Parkinson's disease, as well as neurodevelopmental disorders such as neurofibromatosis type 1, autism, and attention deficit hyperactivity disorder. 

After the talk, guests wanted more...

To advance understanding of these types of brain disorders, Dr. Kahn uses functional magnetic resonance imagining (fMRI) to measure activity in multiple brain systems simultaneously, and to look at the communication and dynamic interactions between regions of the brain.

Here are a few recent breakthroughs in research of Parkinson's Disease from Technion faculty and graduates.   (click here)

For more information about s upporting Parkinson's and other neurodegenerative disease research, please click here


Technion Campus in Haifa
The  Times of Israel  
reported on August 15, 2016 that the Technion-Israel Institute of Technology is ranked #1 in Israel and 69th out of 500 universities around the world, according to the Shanghai Ranking Constituency's Academic Ranking of World Universities

Congratulations Technion faculty, staff, students, and graduates.  A distinction well-deserved!

Revolutionizing cancer treatment through nanotechnology

Associate Professor, Ester Segal Technion  Faculty of Biotechnology &  Food Engineering, and  Head of the Multifunctional Nanomaterials Laboratory
At the new Technion Integrative Cancer Center (TICC), Dr. Segal and her team are developing silicon drug carriers that are promising effective, focused and per s on alized treatments for cancer. Prof. Segal's lab has successfully engineered silicon "containers" (carriers) that are used to release anticancer drugs in a controlled manner. 

Dr. Segal is also helping to develop a "lab on a chip" that can diagnose diseases while a patient waits in the doctor's office. 

"Being a cancer survivor myself and understanding the patients' needs . . . made me believe that although I am not a physician . . . I have the engineering tools that can allow me to bring the power of technology and engineering into cancer treatment."

To hear an interview with Dr. Segal and learn more about the "Lab on a Chip," click here.

Mark Greenberg
American Technion Society
Director, San Diego Chapter

(858) 750-2135